These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 287960)

  • 1. Aspirin.
    Scopp IW; Roehrl PL
    N Y J Dent; 1979; 49(7):218-20. PubMed ID: 287960
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 4th Part: Influence of the enteric polymer dissolution pH on the "in vivo" absorption of aspirin from coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(3):263-76. PubMed ID: 8603
    [No Abstract]   [Full Text] [Related]  

  • 3. Tablets of coated aspirin microspherules--a new dosage form.
    Green DM
    J New Drugs; 1966; 6(5):294-304. PubMed ID: 5339421
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-dose evaluation of a new enteric-coated aspirin preparation.
    Paull P; Day R; Graham G; Champion D
    Med J Aust; 1976 Apr; 1(17):617-9. PubMed ID: 933973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms.
    Bogentoft C; Carlsson I; Ekenved G; Magnusson A
    Eur J Clin Pharmacol; 1978 Dec; 14(5):351-5. PubMed ID: 32046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class experiment with student volunteers illustrating the influence of formulation on absorption of aspirin [proceedings].
    Luscombe DK; Nicholls PJ
    Br J Pharmacol; 1976 Oct; 58(2):312P. PubMed ID: 974427
    [No Abstract]   [Full Text] [Related]  

  • 7. The absorption of Safapryn in patients with arthritis.
    Haslock I; Omar AS; Wright V
    Br J Clin Pract; 1976 Apr; 30(4):89-91. PubMed ID: 1268023
    [No Abstract]   [Full Text] [Related]  

  • 8. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of formulation of enterosoluable preparations on the physiologic availability of the active principle. 1: Effect on the rate of liberation of acetylsalicylic acid from enteric tablets on absorption characteristics in vivo].
    Delporte JP; Jaminet F
    J Pharm Belg; 1975; 30(2):99-113. PubMed ID: 1206458
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
    Laine V; Strandman D; Tikkanen R
    Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acetylsalicylic acid and gastrointestinal bleeding--a study of blood loss and absorption after intake of a gastric juice--resistant preparation].
    Arvidsson B; Magnusson A; Magnusson B; Sölvell L
    Lakartidningen; 1977 Nov; 74(46):4101-2. PubMed ID: 337007
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of the acetylsalicylic acid tablets registered in Finland.
    Perälä-Suominen A
    Ann Clin Res; 1974; 6(0):suppl 11:26-33. PubMed ID: 4855462
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
    Lui CY; Oberle R; Fleisher D; Amidon GL
    J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an enteric coated aspirin preparation.
    Day RO; Paull PD; Champion GD; Graham GG
    Aust N Z J Med; 1976 Feb; 6(1):45-50. PubMed ID: 1065299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW; Walker SE; Leung FY; Little AH
    Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
    [No Abstract]   [Full Text] [Related]  

  • 17. Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration.
    Bogentoft C; Alpsten M; Ekenved G
    J Pharm Pharmacol; 1984 May; 36(5):350-1. PubMed ID: 6145780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin, absorption rate and analgesic effect.
    Levy G
    Anesth Analg; 1965; 44(6):837-41. PubMed ID: 5891911
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.
    Kaniwa N; Aoyagi N; Ogata H; Ejima A; Motoyama H; Yasumi H
    J Pharmacobiodyn; 1988 Aug; 11(8):571-5. PubMed ID: 3236215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of activated charcoal on aspirin absorption in man. Part I.
    Levy G; Tsuchiya T
    Clin Pharmacol Ther; 1972; 13(3):317-22. PubMed ID: 5026372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.